Skadden’s Beijing office, which has an official license to operate as a foreign law firm in the People’s Republic of China (PRC), opened in 1991. We work closely with the firm’s attorneys throughout the region and worldwide in advising PRC clients on capital markets transactions, and mergers and acquisitions, and in counseling foreign clients on investment or acquisition projects in China. Our Asia Investment Management, International Litigation and Arbitration and Antitrust/ Competition Groups also have extensive experience working with clients of our China offices.
Skadden was ranked in Band 1 for Capital Markets: Equity in China in Chambers Greater China 2025 and Tier 1 for Capital Markets (Equity) and Corporate/M&A in Hong Kong in The Legal 500 Asia Pacific 2025. In Chambers, client commentators noted our status as an “M&A juggernaut that continues to operate at the forefront of the market with a bench of experienced practitioners.” In 2024, we were recognized in 13 categories at the China Business Law Awards, including for Best International Law Firm (for six consecutive years) and in the Pro Bono category (for three consecutive years). We also were named International Capital Markets Firm of the Year at the 2022 China Law & Practice Awards. We are consistently recognized by Asian Legal Business as a Tier 1 firm in its annual M&A Rankings, most recently in 2024.
Corporate
Attorneys in the Beijing office represent both Chinese and non-Chinese bidders and targets, financial investors, special committees and private equity sponsors in inbound and outbound cross-border M&A and private equity transactions, including share acquisitions and dispositions, asset acquisitions and divestitures, joint ventures and going-private transactions. Skadden has been involved in a large number of going-private transactions by China-based, U.S.-listed companies since 2011.
Our Capital Markets Group is a powerhouse in IPO and high-yield work, representing high-profile issuers in the region as well as major financial institutions. Our team has advised on dozens of NYSE and Nasdaq IPOs by China-based private companies, as well as some of the biggest and most innovative Hong Kong IPOs and homecoming listings. The firm played a primary role in the IPOs of a “who’s who” of Chinese new economy companies, including those leading players in the internet, consumer, fintech, education, health care and renewable energy sectors.
International Litigation and Arbitration
Skadden’s Asia Pacific International Litigation and Arbitration Group provides the full range of international dispute resolution services across the region. Members of the practice have handled cases under the auspices of the HKIAC, CIETAC, SIAC, ICC and LCIA, as well as on ICSID and UNCITRAL claims. The team also handles regulatory and cross-border investigations and includes a Foreign Corrupt Practices Act team focused on Hong Kong and China.
Antitrust/Competition
Skadden’s antitrust/competition practice represents clients on a full range of competition law issues raised in multinational M&A and other transactions. Such issues arise in outbound Chinese investments around the world, as well as foreign investments in Chinese entities, including the creation of joint ventures between Chinese and foreign companies. The antitrust/competition practice also represents clients across multiple jurisdictions with anticompetitive conduct issues relating to cartels and potential abuses of dominance, and has broad experience in designing and auditing global competition compliance programs.
Investment Management
Our investment management attorneys represent leading investors, sponsors and strategic parties in Asia in connection with the formation, capitalization and operation of investment funds and fund managers, including venture funds and venture portfolio transactions.
Languages
Our attorneys in Beijing speak fluent Mandarin and English.
